Biomaterial Database

Sialidase activity of the "Streptococcus milleri group" and other viridans group streptococci. 1990

D Beighton, and R A Whiley

Hunterian Dental Research Unit, London Hospital Medical College, Whitechapel, England.

Viridans group streptococci were examined for the production of sialidase (neuraminidase) activity, using the fluorescent substrate 4-methylumbelliferyl-alpha-D-N-acetylneuraminic acid in a simple and rapid (15-min) assay. Sialidase was produced by all strains of Streptococcus oralis and S. intermedius and by a majority of S. mitis strains. S. mutans, S. sobrinus, S. gordonii, S. sanguis, S. vestibularis, S. salivarius, S. anginosus, S. constellatus, "S. parasanguis," and the "tufted fibril group" were uniformly negative. Sialidase production may be a useful characteristic to assist in the identification of viridans group streptococci.

UI	MeSH Term	Description	Entries
D009439	Neuraminidase	An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992)	Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680	Sensitivity and Specificity	Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)	Specificity,Sensitivity,Specificity and Sensitivity
D013291	Streptococcus	A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment.

Related Publications

D Beighton, and R A Whiley

The relative cariogenicities of Streptococcus milleri and other viridans group streptococci in gnotobiotic hooded rats.

January 1978, Archives of oral biology,

D Beighton, and R A Whiley

Restricted distribution of Streptococcus milleri carbohydrate type antigens amongst other viridans streptococci.

September 1992, Journal of medical microbiology,

D Beighton, and R A Whiley

Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci.

May 1996, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,

D Beighton, and R A Whiley

Milleri group streptococcus--a stepchild in the viridans family.

September 2012, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,

D Beighton, and R A Whiley

Activity of DX-619 compared to other agents against viridans group streptococci, Streptococcus bovis, and Cardiobacterium hominis.

December 2006, Antimicrobial agents and chemotherapy,

D Beighton, and R A Whiley

Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococci.

March 2007, Diagnostic microbiology and infectious disease,

D Beighton, and R A Whiley

Assessment of the Optochin Susceptibility Test to Differentiate Streptococcus pneumoniae from other Viridans Group Streptococci.

March 2021, Clinical laboratory,

D Beighton, and R A Whiley

Variants of the bile: solubility test to differentiate Streptococcus pneumoniae from other viridans group streptococci.

July 2019, Future microbiology,